Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
DNA Ginkgo Bioworks
- 9.440
- -0.890-8.62%
Close Dec 13 16:00 ET
- 9.310
- -0.130-1.38%
Post 20:02 ET
542.60MMarket Cap-0.73P/E (TTM)
10.480High9.260Low1.50MVolume10.280Open10.330Pre Close14.31MTurnover3.83%Turnover RatioLossP/E (Static)57.48MShares75.20052wk High0.68P/B370.15MFloat Cap5.26052wk Low--Dividend TTM39.21MShs Float634.560Historical High--Div YieldTTM11.81%Amplitude5.260Historical Low9.537Avg Price1Lot Size
Ginkgo Bioworks Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -40.72%-103.5M | -14.76%-84.39M | 1.46%-89.26M | -17.17%-295.5M | 44.68%-57.83M | -159.34%-73.55M | 26.03%-73.53M | -355.25%-90.59M | 0.64%-252.2M | 36.85%-104.53M |
| Net income from continuing operations | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.61%-892.87M | -22.31%-211.69M | 54.80%-302.89M | 74.15%-173.32M | 65.41%-204.97M | -14.69%-2.11B | 89.22%-173.08M |
| Operating gains losses | -64.00%12.4M | -46.13%3.59M | -75.75%1.6M | 268.76%95.64M | 313.65%47.92M | 64.55%34.43M | -73.67%6.67M | 108.22%6.62M | -287.58%-56.67M | 61.25%-22.43M |
| Depreciation and amortization | -18.48%17.17M | -1.82%17.33M | -32.12%12.87M | 61.07%71.55M | -20.83%13.88M | 166.14%21.06M | 75.96%17.65M | 112.06%18.96M | 52.78%44.42M | 119.14%17.54M |
| Deferred tax | ---- | ---- | ---- | 94.52%-801K | ---- | ---- | ---- | ---- | ---14.61M | ---- |
| Other non cash items | -29.67%7.52M | -4.11%16.16M | 47.07%21.09M | 495.56%49.85M | 165.50%7.97M | 30.45%10.7M | 220.70%16.85M | 169.29%14.34M | 39.83%-12.6M | -26.95%-12.16M |
| Change In working capital | -5,272.11%-98.04M | 149.49%5.88M | -79.03%312K | 180.63%29.84M | 628.41%42.06M | -104.39%-1.83M | 79.06%-11.88M | 110.71%1.49M | 39.86%-37.01M | 91.38%-7.96M |
| -Change in receivables | -186.62%-5M | -64.40%5.67M | -1,187.07%-6.77M | -9.01%50.07M | -16.24%28.9M | -90.24%5.77M | 533.87%15.92M | 98.49%-526K | 148.23%55.02M | 140.39%34.5M |
| -Change in prepaid assets | 16.80%1.72M | -86.74%616K | -84.49%1.15M | 222.88%10.47M | 77.58%-3.08M | 71.53%1.47M | 9.37%4.65M | 5,806.35%7.44M | -136.29%-8.52M | -49.95%-13.75M |
| -Change in payables and accrued expense | -5,029.95%-41.96M | 99.97%-7K | -43.02%10.87M | 131.13%15.72M | 153.16%20.54M | 91.50%-818K | 39.97%-23.08M | -47.33%19.08M | -218.65%-50.48M | -345.73%-38.63M |
| -Change in other current assets | 12.60%5.49M | 1,268.59%14.25M | -212.40%-707K | -16.31%11.85M | -62.16%5.3M | 765.72%4.87M | 139.57%1.04M | -71.56%629K | 2,725.97%14.15M | 2,879.76%14.01M |
| -Change in other current liabilities | -47.05%-7.52M | 91.32%-544K | 83.25%-1.32M | -107.68%-22.35M | -0.92%-3.06M | -420.30%-5.11M | -143.79%-6.27M | 66.56%-7.9M | -157.79%-10.76M | 70.96%-3.04M |
| -Change in other working capital | -533.80%-50.77M | -240.66%-14.1M | 83.10%-2.91M | 1.37%-35.92M | -521.20%-6.54M | 48.84%-8.01M | 86.71%-4.14M | -250.59%-17.23M | -715.43%-36.42M | 67.61%-1.05M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -40.72%-103.5M | -14.76%-84.39M | 1.46%-89.26M | -17.17%-295.5M | 44.68%-57.83M | -159.34%-73.55M | 26.03%-73.53M | -355.25%-90.59M | 0.64%-252.2M | 36.85%-104.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -201.69%-10.2M | -139.14%-26.84M | 37.62%-12.11M | -19.73%-80.69M | -256.94%-46.67M | 92.73%-3.38M | 23.45%-11.22M | 46.05%-19.41M | 8.00%-67.39M | 603.41%29.74M |
| Net PPE purchase and sale | -241.05%-14.69M | -153.05%-26.84M | 65.49%-6.71M | 30.41%-36.37M | 92.16%-2.02M | 67.95%-4.31M | -11.02%-10.61M | -451.99%-19.44M | 7.52%-52.27M | -403.62%-25.76M |
| Net business purchase and sale | --0 | --0 | ---5.4M | -261.30%-42.98M | -152.18%-42.98M | --0 | --0 | --0 | 321.31%26.65M | 781.68%82.37M |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 26.18%-3.69M | --10M |
| Net other investing changes | ---- | ---- | ---- | 96.48%-1.34M | 95.45%-1.68M | -82.67%926K | ---617K | --27K | -12,625.66%-38.08M | ---36.87M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -201.69%-10.2M | -139.14%-26.84M | 37.62%-12.11M | -19.73%-80.69M | -256.94%-46.67M | 92.73%-3.38M | 23.45%-11.22M | 46.05%-19.41M | 8.00%-67.39M | 603.41%29.74M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -47.62%-465K | 83.64%-226K | 4.84%-845K | -103.37%-3.22M | -100.65%-632K | 19.44%-315K | -63.82%-1.38M | 25.50%-888K | -93.79%95.34M | 985.29%97.76M |
| Net issuance payments of debt | 39.21%-200K | 38.65%-200K | 8.70%-294K | -4.69%-1.3M | 2.15%-318K | -8.58%-329K | -0.93%-326K | -12.59%-322K | -10.15%-1.24M | 9.47%-325K |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 497.24%99.3M | ---- |
| Proceeds from stock option exercised by employees | --0 | 16.67%14K | 483.33%70K | -61.25%93K | --14K | --55K | --12K | -84.00%12K | 43.71%240K | ---- |
| Net other financing activities | -546.34%-265K | 96.25%-40K | -7.44%-621K | 32.17%-2.01M | 77.46%-328K | 53.41%-41K | -139.78%-1.07M | 41.08%-578K | -100.19%-2.97M | 86.54%-1.46M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -47.62%-465K | 83.64%-226K | 4.84%-845K | -103.37%-3.22M | -100.65%-632K | 19.44%-315K | -63.82%-1.38M | 25.50%-888K | -93.79%95.34M | 985.29%97.76M |
| Net cash flow | ||||||||||
| Beginning cash position | -33.81%775.74M | -29.51%887.21M | -27.75%989.58M | -14.02%1.37B | -18.65%1.09B | -17.51%1.17B | -18.05%1.26B | -14.02%1.37B | 312.81%1.59B | -23.78%1.35B |
| Current changes in cash | -47.79%-114.17M | -29.39%-111.46M | 7.82%-102.21M | -69.19%-379.41M | -557.67%-105.14M | -2.67%-77.25M | 25.04%-86.14M | -94.28%-110.89M | -118.58%-224.26M | 113.33%22.97M |
| Effect of exchange rate changes | 82.05%-35K | 96.59%-16K | -503.85%-157K | -164.76%-588K | -90.72%102K | -124.14%-195K | -388.54%-469K | -225.00%-26K | 4,878.95%908K | 10,090.91%1.1M |
| End cash Position | -39.56%661.54M | -33.81%775.74M | -29.51%887.21M | -27.75%989.58M | -27.75%989.58M | -18.65%1.09B | -17.51%1.17B | -18.05%1.26B | -14.02%1.37B | -14.02%1.37B |
| Free cash flow | -52.17%-118.59M | -27.97%-111.42M | 12.78%-95.97M | -10.45%-336.3M | 52.93%-61.28M | -86.29%-77.93M | 20.11%-87.07M | -368.63%-110.03M | 1.89%-304.47M | 23.72%-130.18M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.